JP2019530750A5 - - Google Patents

Download PDF

Info

Publication number
JP2019530750A5
JP2019530750A5 JP2019539737A JP2019539737A JP2019530750A5 JP 2019530750 A5 JP2019530750 A5 JP 2019530750A5 JP 2019539737 A JP2019539737 A JP 2019539737A JP 2019539737 A JP2019539737 A JP 2019539737A JP 2019530750 A5 JP2019530750 A5 JP 2019530750A5
Authority
JP
Japan
Prior art keywords
therapeutically effective
free amino
preparation according
amino acids
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019539737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019530750A (ja
JP7267546B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/055167 external-priority patent/WO2018067717A1/en
Publication of JP2019530750A publication Critical patent/JP2019530750A/ja
Publication of JP2019530750A5 publication Critical patent/JP2019530750A5/ja
Priority to JP2023060554A priority Critical patent/JP2023100617A/ja
Application granted granted Critical
Publication of JP7267546B2 publication Critical patent/JP7267546B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019539737A 2016-10-04 2017-10-04 アミノ酸組成物及びその使用 Active JP7267546B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023060554A JP2023100617A (ja) 2016-10-04 2023-04-04 アミノ酸組成物及びその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662403965P 2016-10-04 2016-10-04
US62/403,965 2016-10-04
US201662421443P 2016-11-14 2016-11-14
US62/421,443 2016-11-14
PCT/US2017/055167 WO2018067717A1 (en) 2016-10-04 2017-10-04 Amino acid compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023060554A Division JP2023100617A (ja) 2016-10-04 2023-04-04 アミノ酸組成物及びその使用

Publications (3)

Publication Number Publication Date
JP2019530750A JP2019530750A (ja) 2019-10-24
JP2019530750A5 true JP2019530750A5 (pt) 2020-11-12
JP7267546B2 JP7267546B2 (ja) 2023-05-02

Family

ID=61831937

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019539737A Active JP7267546B2 (ja) 2016-10-04 2017-10-04 アミノ酸組成物及びその使用
JP2023060554A Pending JP2023100617A (ja) 2016-10-04 2023-04-04 アミノ酸組成物及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023060554A Pending JP2023100617A (ja) 2016-10-04 2023-04-04 アミノ酸組成物及びその使用

Country Status (9)

Country Link
US (1) US11576884B2 (pt)
EP (1) EP3522882A4 (pt)
JP (2) JP7267546B2 (pt)
CN (2) CN115645388A (pt)
AU (1) AU2017338887B2 (pt)
BR (1) BR112019006742A2 (pt)
CA (2) CA3039514C (pt)
MX (1) MX2019003821A (pt)
WO (1) WO2018067717A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101758424B1 (ko) 2010-09-24 2017-07-14 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 위장 기능을 증진시키기 위한 물질 및 방법
JP6378307B2 (ja) 2013-03-11 2018-08-22 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 肺機能を改善するためならびに放射線誘発肺合併症の予防および/または処置のための物質および方法
KR20200139776A (ko) * 2018-04-04 2020-12-14 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 피부 치료용 조성물
WO2020028129A1 (en) * 2018-07-30 2020-02-06 Almeda Labs Llc Cardioprotective amino acid formulations
RU2709502C1 (ru) * 2019-09-23 2019-12-18 Виктор Александрович Сисев Фармацевтическая композиция для парентерального капельного введения
US20230045151A1 (en) * 2020-01-13 2023-02-09 Monash University Compositions and methods
JP7470376B2 (ja) * 2020-03-31 2024-04-18 国立大学法人山口大学 顎下腺の萎縮抑制剤及び創傷治癒促進剤
JP2023533617A (ja) * 2020-07-02 2023-08-03 ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド 水分補給を促進するための製剤およびその使用方法
CN114097952A (zh) * 2020-08-28 2022-03-01 河北科星药业有限公司 毛丝鼠专用的营养添加剂、其制备方法及应用
WO2023130094A2 (en) * 2022-01-03 2023-07-06 Entrinsic, LLC Formulations and methods for skin care
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016757A2 (en) 1991-03-05 1994-08-04 Miris Medical Corporation Apparatus for providing a timed release of an amount of aerosol medication
EP0940154B1 (en) 1991-07-02 2007-04-18 Nektar Therapeutics Device for delivering aerosolized medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
HUP9800049A3 (en) 1995-02-23 1999-01-28 Novartis Nutrition Ag Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
WO1998029096A1 (en) 1996-12-31 1998-07-09 Inhale Therapeutic Systems Aerosolized hydrophobic drug
WO2000029620A1 (en) 1998-11-13 2000-05-25 Children's Hospital Of Los Angeles Methods of facilitating vascular growth
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
US20050192210A1 (en) 2004-03-01 2005-09-01 Rothbard Jonathan B. Compositions and methods for treating diseases
US20070010459A1 (en) 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
WO2008015374A2 (en) * 2006-08-04 2008-02-07 Shs International Ltd Protein free formula
EP2185004B1 (en) * 2007-08-03 2017-03-15 Aminotech AS Amino acid and peptide products
JP5576097B2 (ja) * 2009-11-17 2014-08-20 大塚製薬株式会社 気道抵抗改善剤
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
IT1397023B1 (it) 2009-11-27 2012-12-20 Professional Dietetics Srl Composizioni comprendenti amminoacidi, per il trattamento della broncopneumopatia cronica ostruttiva
KR20120113259A (ko) 2010-01-08 2012-10-12 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 생물막의 처리에서 사용하기 위한 d-아미노산
KR101758424B1 (ko) * 2010-09-24 2017-07-14 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 위장 기능을 증진시키기 위한 물질 및 방법
JP2012214451A (ja) * 2011-03-25 2012-11-08 En Otsuka Pharmaceutical Co Ltd 炎症性疾患用アミノ酸組成物
WO2013093947A1 (en) * 2011-12-21 2013-06-27 Motolese Pasquale Cosmetic composition and uses thereof in the treatment of lipodystrophies
EA034014B1 (ru) 2012-02-08 2019-12-19 Юниверсити Оф Флорида Рисёч Фаундейшн, Инк. Способ лечения субъекта с диареей, вызванной ротавирусом
JP6378307B2 (ja) * 2013-03-11 2018-08-22 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 肺機能を改善するためならびに放射線誘発肺合併症の予防および/または処置のための物質および方法
DE102013224993A1 (de) * 2013-12-05 2015-06-11 Henkel Ag & Co. Kgaa Haarbehandlungsmittel mit substituierten Silikon(en)
US10413528B2 (en) * 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
MX2017006748A (es) * 2014-11-24 2017-08-28 Entrinsic Health Solutions Inc Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.

Similar Documents

Publication Publication Date Title
JP2019530750A5 (pt)
JP2019503365A5 (pt)
JP2017075173A5 (pt)
JP2020033360A5 (pt)
JP2009510044A5 (pt)
JP2015517489A5 (pt)
JP2017528503A5 (pt)
JP2014506321A5 (pt)
JP2010518122A5 (pt)
BR112013029246A2 (pt) 4-amino-5-flúor-3-[6- (4-metilpiperazin- 1 - il) - 1h - benzimidazol - 2 - il] - 1h - quinolin-2-ona para uso no tratamento de carcinoma adenoide cístico
JP2020532531A5 (pt)
JP2009500045A5 (pt)
JP2009505979A5 (pt)
JP2020521797A5 (pt)
JP2014050390A5 (pt)
JP2013510169A5 (pt)
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
JP2016512817A5 (pt)
MX2020007971A (es) Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar.
DOP2021000015A (es) Forma de dosificación farmacéutica administrable por vía oral con liberación modificada
JP2008533079A5 (pt)
PT2285393E (pt) Composições para o tratamento de distúrbios do tracto respiratório superior e síndromes gripais
US20060240127A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
JP2017516767A5 (pt)
US8980826B2 (en) Method of treating chronic obstructive pulmonary disease